Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 72603-145

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 72603-145). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container100mg100 (Container100mg100)

Metoprolol Succinate Extended-Release Tablets, USP 100 mg film-coated tablets label from Northstar Rx LLC. The label states each tablet contains 95 mg metoprolol succinate equivalent to 100 mg metoprolol tartrate, USP, with 100 tablets per package. Manufactured by Dr. Reddy's Laboratories Limited in India. Includes dosage, storage, and warning instructions, and a barcode.*

FDA Label Image

Container100mg500 (Container100mg500)

Label for Metoprolol Succinate Extended-Release Tablets USP, 100 mg strength, film-coated, oral tablets in a package of 500 tablets. The product is manufactured by Dr. Reddy's Laboratories Limited and labeled for Northstar Rx LLC. The label includes storage instructions and a barcode.*

FDA Label Image

Container200mg100 (Container200mg100)

Metoprolol succinate Extended-Release Tablets, USP 200 mg film-coated tablets in a package of 100. The label states the product is manufactured by Dr. Reddy's Laboratories Limited for Northstar Rx LLC, Memphis, TN, and includes storage information and warnings. The NDC is 72603-145-01.*

FDA Label Image

Container200mg500 (Container200mg500)

Metoprolol succinate extended-release tablets USP label for 200 mg strength, film-coated, oral dosage form. The package contains 500 tablets. Manufactured by Dr. Reddy's Laboratories Limited in India and labeled for Northstar Rx LLC. Includes storage instructions and a barcode.*

FDA Label Image

Figure (Figure)

A forest plot chart titled "Results for Subgroups in MERIT-HF" showing relative risk and 95% confidence intervals for metoprolol succinate extended-release tablets versus placebo across various patient subgroups. The chart is divided into three panels comparing total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. Each panel includes subgroups such as geographic region, NYHA class, ejection fraction ranges, ischemic etiology, sex, race, myocardial infarction history, diabetes status, hypertension history, and heart rate categories.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Metoprolol succinate, illustrating the molecular arrangement of its atoms and functional groups as seen in the labeled structural formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.